Is ApoB useful for Wechseljahre?

Apolipoprotein B (ApoB) is a useful marker for cardiovascular risk assessment, especially during menopause when estrogen decline leads to unfavorable lipid changes. ApoB reflects the total number of atherogenic particles and is considered a more accurate risk predictor than LDL-C alone. Evidence is human-strong for ApoB as a CVD risk marker, but its specific utility for menopause management is indirect. Guidelines (e.g., ESC/EAS) support ApoB testing in intermediate- to high-risk individuals. However, ApoB is not a diagnostic tool for menopause itself. Caveat: Results should be interpreted alongside other lipids and clinical factors. Hormone replacement therapy may lower ApoB, but decisions require individualized medical advice.